INTELLIGENT BIO SOLUTIONS INC. current report, 18 July 2022

Business Context and Reporting Period

This Form 8-K was filed by GBS Inc. (trading symbol: GBS) on July 18, 2022. The registrant is incorporated in Delaware and is classified as an emerging growth company. The report details a corporate governance action taken by the Board of Directors on July 18, 2022.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change to the company's Bylaws and does not contain financial performance data.

Material Changes

The Board adopted an amendment to Section 2.4 of the Company's Amended and Restated Bylaws. The quorum requirement for stockholder meetings was reduced from a majority of the capital stock issued and outstanding to not less than one-third of the capital stock issued and outstanding. This change took effect immediately upon adoption.

Outlook, Risks, and Management Commentary

The Bylaws Amendment was adopted to facilitate achieving a quorum at the Company's 2022 Annual Meeting of Stockholders. The Annual Meeting was originally convened on June 16, 2022, and reconvened on July 13, 2022, but failed to achieve a quorum on both occasions due to insufficient stockholder attendance. Consequently, the Annual Meeting was adjourned to a date to be determined and announced to stockholders. The filing includes the amended Bylaws as exhibits.

Key Facts for Investor Verification

  • The quorum requirement for stockholder meetings has been lowered to one-third of outstanding shares.
  • The 2022 Annual Meeting has been adjourned indefinitely pending a new date announcement.
  • The company failed to achieve a quorum at two previous attempts to hold the Annual Meeting.
  • No financial results or operational metrics are disclosed in this specific filing.